http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013139670-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013139670-A |
| titleOfInvention | APPLICATION OF THE COMBINATION OF ANGIOTENZINE-TURNING ENZYME INHIBITOR AND EPIPHYSIS HORMONE FOR TREATMENT OF ISCHEMIC HEART DISEASE IN ELDERLY PATIENTS |
| abstract | 1. The use of a pharmaceutical combination of an angiotensin-converting enzyme inhibitor and an pineal gland hormone for separate parallel and / or sequential administration for the treatment of coronary heart disease in elderly patients, characterized in that fosinopril is used as an angiotensin-converting enzyme inhibitor, and an epiphysis hormone is used melatonin, while the normalization of the elderly patient occurs on 3-4 days. 2. The use according to claim 1, wherein fosinopril is administered at a dose of 10 mg 2 times a day. The use according to claim 1, wherein melatonin is administered in a dose of 3 mg once a day. The use of claim 3, wherein melatonin is administered 30 minutes before bedtime. |
| priorityDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.